CVSA SEC Filing News — Covista Inc.

Latest SEC filings for Covista Inc. (CVSA) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-16.

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, socia…
Sector: Consumer Defensive Industry: Education & Training Services Market Cap: $4.4B CIK: 730464
20
Total Filings
0
Bullish Classifications
5
Bearish Classifications
14
Insider Transactions
1
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for CVSA currently lean bearish. Of the 20 filing records displayed, 5 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
CVSA Filing Activity Snapshot 2026-08-06 — 2026-10-16
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$1.08M
Beard, Stephen W. (Chairman & CEO) · 2026-10-09
8,306 shares · Form 4
Form 144 Notices
4
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 14 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 14 filings in this group are Form 4s for Covista Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 14 insider filings shown, the breakdown is 7 compensation award, 5 open-market sale, 1 gift and 1 tax withholding. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×7
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Gift ×1
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Tax withholding ×1
Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.
Form 4 Compensation award Tax / Compensation Filing 2026-10-16

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Storms Leslie (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 259 $127.24 $33.0K
Filing: Form 4 (Insider Transaction) Insider: Storms Leslie (Director) Shares: 259
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-10-16

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Hill Sara (CHRO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,322 $127.24 $168.2K
Filing: Form 4 (Insider Transaction) Insider: Hill Sara (CHRO) Shares: 1,322
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-10-16

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

CHIU EMILY C (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 259 $127.24 $33.0K
Filing: Form 4 (Insider Transaction) Insider: CHIU EMILY C (Director) Shares: 259
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-09

CVSA insider Beard, Stephen W. (Chairman & CEO) sold 8,306 shares (~$1.08M)

Beard, Stephen W., listed as Chairman & CEO at Covista Inc., reported an open-market sale of 8,306 CVSA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,639 $130.37 $474.4K
S Open-market sale 4,667 $130.77 $610.3K
Filing: Form 4 (Insider Transaction) Insider: Beard, Stephen W. (Chairman & CEO) Shares: 8,306 Est. Value: $1.08M
View on SEC EDGAR → Open Filing Document →
Form 4 Gift Tax / Compensation Filing 2026-09-01

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

MALAFRONTE MICHAEL W (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code Nature Shares Price Value
G Gift 2,500 — —
Filing: Form 4 (Insider Transaction) Insider: MALAFRONTE MICHAEL W (Director) Shares: 2,500
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-28

CVSA insider Gangadharan Manjunath (VP, Chief Accounting Officer) sold 1,802 shares (~$247.2K)

Gangadharan Manjunath, listed as VP, Chief Accounting Officer at Covista Inc., reported an open-market sale of 1,802 CVSA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,802 $137.18 $247.2K
Filing: Form 4 (Insider Transaction) Insider: Gangadharan Manjunath (VP, Chief Accounting Officer) Shares: 1,802 Est. Value: $247.2K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-25

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Betz Michael (Pres. Walden University & CDO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 945 $132.35 $125.1K
A Compensation award 7,320 $132.35 $968.8K
F Tax withholding on vested shares 3,302 $132.35 $437.0K
A Compensation award 5,124 $132.35 $678.2K
F Tax withholding on vested shares 2,311 $132.35 $305.9K
Filing: Form 4 (Insider Transaction) Insider: Betz Michael (Pres. Walden University & CDO) Shares: 19,002
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-25

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Phelan Robert J. (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,279 $132.35 $169.3K
A Compensation award 7,056 $132.35 $933.9K
F Tax withholding on vested shares 3,126 $132.35 $413.7K
A Compensation award 10,080 $132.35 $1.33M
F Tax withholding on vested shares 4,466 $132.35 $591.1K
Filing: Form 4 (Insider Transaction) Insider: Phelan Robert J. (Chief Financial Officer) Shares: 26,007
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-25

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Gangadharan Manjunath (VP, Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 188 $132.35 $24.9K
A Compensation award 1,050 $132.35 $139.0K
F Tax withholding on vested shares 308 $132.35 $40.8K
A Compensation award 1,500 $132.35 $198.5K
F Tax withholding on vested shares 440 $132.35 $58.2K
Filing: Form 4 (Insider Transaction) Insider: Gangadharan Manjunath (VP, Chief Accounting Officer) Shares: 3,486
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-25

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

BECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 784 $132.35 $103.8K
A Compensation award 4,242 $132.35 $561.4K
F Tax withholding on vested shares 1,922 $132.35 $254.4K
A Compensation award 6,060 $132.35 $802.0K
F Tax withholding on vested shares 2,746 $132.35 $363.4K
Filing: Form 4 (Insider Transaction) Insider: BECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) Shares: 15,754
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-25

CVSA insider Form 4 filed for equity award, exercise, or tax withholding

Beard, Stephen W. (Chairman & CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 9,621 $132.35 $1.27M
A Compensation award 53,144 $132.35 $7.03M
F Tax withholding on vested shares 23,543 $132.35 $3.12M
A Compensation award 75,920 $132.35 $10.05M
F Tax withholding on vested shares 33,633 $132.35 $4.45M
Filing: Form 4 (Insider Transaction) Insider: Beard, Stephen W. (Chairman & CEO) Shares: 195,861
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-13

CVSA insider Beard, Stephen W. (Chairman & CEO) sold 3,545 shares (~$462.1K)

Beard, Stephen W., listed as Chairman & CEO at Covista Inc., reported an open-market sale of 3,545 CVSA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,545 $130.34 $462.1K
Filing: Form 4 (Insider Transaction) Insider: Beard, Stephen W. (Chairman & CEO) Shares: 3,545 Est. Value: $462.1K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-11

CVSA insider Phelan Robert J. (Chief Financial Officer) sold 2,186 shares (~$295.4K)

Phelan Robert J., listed as Chief Financial Officer at Covista Inc., reported an open-market sale of 2,186 CVSA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,186 $135.15 $295.4K
Filing: Form 4 (Insider Transaction) Insider: Phelan Robert J. (Chief Financial Officer) Shares: 2,186 Est. Value: $295.4K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-11

CVSA insider BECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) sold 4,526 shares (~$614.7K)

BECK DOUGLAS G., listed as SVP, GC, Corp. Sec & ISS at Covista Inc., reported an open-market sale of 4,526 CVSA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 4,526 $135.81 $614.7K
Filing: Form 4 (Insider Transaction) Insider: BECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) Shares: 4,526 Est. Value: $614.7K
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 4 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Covista Inc. has 4 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-09

CVSA Form 144 filed for proposed insider sale by Stephen Beard (4,667 shares) ~$603.8K

Stephen Beard filed a Form 144 with the SEC indicating intent to sell CVSA (Covista Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Stephen Beard Shares: 4,667 Est. Value: $603.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-08

CVSA Form 144 filed for proposed insider sale by Stephen Beard (3,639 shares) ~$474.1K

Stephen Beard filed a Form 144 with the SEC indicating intent to sell CVSA (Covista Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Stephen Beard Shares: 3,639 Est. Value: $474.1K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-27

CVSA Form 144 filed for proposed insider sale by MANJUNATH GANGADHARAN (1,802 shares) ~$248.3K

MANJUNATH GANGADHARAN filed a Form 144 with the SEC indicating intent to sell CVSA (Covista Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MANJUNATH GANGADHARAN Shares: 1,802 Est. Value: $248.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-11

CVSA Form 144 filed for proposed insider sale by Stephen Beard (3,545 shares) ~$448.4K

Stephen Beard filed a Form 144 with the SEC indicating intent to sell CVSA (Covista Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Stephen Beard Shares: 3,545 Est. Value: $448.4K
View on SEC EDGAR → Open Filing Document →
Material Events 1 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There is 1 in this period for Covista Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-23

CVSA filed 8-K — material company event

Covista Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 annual report (10-K) for Covista Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-K Annual Report 2026-08-06

CVSA filed Annual Report (10-K)

Covista Inc. filed its annual report with the SEC. This report includes audited financial statements, business overview, risk factors, and management discussion.

Filing: 10-K (Annual Report)
View on SEC EDGAR → Open Filing Document →

How we classify Covista Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CVSA. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CVSA SEC Filings

More Tools for CVSA

CVSA Full Stock Analysis CVSA Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper CVSA analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CVSA stock analysis page.

CVSA Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer